![]() |
|
|
Vol. 30, Issue 2, 119-128, February 2002
Unité de Toxicologie et de Métabolisme Comparés
des Xénobiotiques, Unité Mixte Recherche Institut National
de la Recherche Agronomique et Direction Générale de
l'Enseignement et de la Recherche, Ecole Nationale
Vétérinaire de Lyon, Marcy l'étoile, France (V.L.,
C.L.-S., P.D., E.B.); Laboratoire de Physiologie des Régulations
Energétiques, Cellulaires et Moléculaires, Unité
Mixte Recherche 5578 Centre National de la Recherche
Scientifique-UCB-Lyon 1, Faculté des Sciences, Villeurbanne,
France (J.L.)
The expression of flavin-containing monooxygenases (FMOs) in dog
liver microsomes was suggested by a high methimazole
S-oxidase activity. When the reaction was catalyzed by
dog liver microsomes, apparent Vmax
and Km values were 6.3 nmol/min/mg and
14 µM, respectively. This reaction was highly inhibited (73%) in the
presence of imipramine, but it was also weakly affected by
trimethylamine, suggesting the involvement of different isoforms.
The sequences of dog FMO1 and FMO3 were obtained by reverse
transcription-polymerase chain reaction and 5'/3' terminal
extension. The cDNAs of dog FMO1 and dog FMO3 encode proteins of 532 amino acids, which contain the NADPH- and FAD-binding sites. The dog
FMO1 amino acid sequence is 88, 86, and 89% identical to sequences of
human, rabbit, and pig FMO1, respectively. The dog FMO3 amino acid
sequence is 83, 84, and 82% identical to sequences of human, rabbit,
and rat FMO3, respectively. Dog FMO1 and dog FMO3 exhibited only 56%
identities. The FMO1 and FMO3 recombinant proteins and the FMO1 and
FMO3 microsomal proteins migrated with the same mobility (56 kDa), as
determined in SDS-polyacrylamide gel electrophoresis and
immunoblotting. By Western blotting, dog FMO1 and dog FMO3 were
detected in microsomes from liver and lung but not in kidney
microsomes. By Northern blotting, the probe for FMO1 specifically
hybridized a 2.6-kilobase (kb) transcript in liver and lung samples
only. The probe for FMO3 hybridized two transcripts of approximately 3 and 4.2 kb in the liver and lung samples.
This article has been cited by other articles:
![]() |
A. J. Lickteig, R. Riley, R. J. Melton, B. A. Reitz, H. D. Fischer, and J. C. Stevens Expression and Characterization of Functional Dog Flavin-Containing Monooxygenase 3 Drug Metab. Dispos., October 1, 2009; 37(10): 1987 - 1990. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Novick and A. A. Elfarra Purification and Characterization of Flavin-Containing Monooxygenase Isoform 3 from Rat Kidney Microsomes Drug Metab. Dispos., December 1, 2008; 36(12): 2468 - 2474. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. V. Karanam, C. J. Welch, V. G. Reddy, J. Chilenski, M. Biba, and S. Vincent Drug Metab. Dispos., October 1, 2004; 32(10): 1061 - 1068. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Stevens, R. J. Melton, M. J. Zaya, and L. C. Engel Expression and Characterization of Functional Dog Flavin-Containing Monooxygenase 1 Mol. Pharmacol., February 1, 2003; 63(2): 271 - 275. [Abstract] [Full Text] [PDF] |
||||